|
|
||||||||
Ann Thorac Surg 2005;80:982-988
© 2005 The Society of Thoracic Surgeons
Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, United Kingdom
Accepted for publication March 16, 2005.
* Address reprint requests to Professor Angelini, Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, BS2 8HW, UK (Email: G.D.Angelini{at}bristol.ac.uk).
| Abstract |
|---|
|
|
|---|
METHODS: Fifty-nine children (median age 78 months; interquartile range, 39130) undergoing correction of simple congenital heart defects were randomized to receive either hypothermic (28°C) or normothermic (3537°C) CPB. Troponin I and 8-isoprostane, complement activation C3a, interleukin (IL) -6, -8, and -10, were measured preoperatively, on removal of the aortic cross clamp, 30 minutes, 6, and 24 hours postoperatively.
RESULTS: Troponin I and 8-isoprostane were significantly raised, compared to baseline, in both groups, and remained high at 24 hours. Overall, troponin I and 8-isoprostane levels were 37% and 84% higher in the hypothermic than in the normothermic group, respectively (ratio 1.37, 95% CI 1.00 to 1.88, p = 0.053 and 1.84, 95% CI 1.22 to 2.78, p = 0.0045, respectively), and there was no evidence to suggest the treatment effect changed significantly over the time points measured (p = 0.63). Adjusting for aortic cross-clamp time reduced the effect of hypothermia on troponin (p = 0.18) but not on 8-isoprostane levels (p = 0.0028). The C3a, IL-6, and IL-8 release was similar in the two groups. The IL-10 release between the groups changed over time (p = 0.059) and examining differences at individual time points highlighted a statistically significant difference at the end of the cross-clamp time (p = 0.0079).
CONCLUSIONS: Normothermic CPB is associated with reduced oxidative stress compared with hypothermic CPB, and similar myocardial reperfusion injury and whole body inflammatory response, in children undergoing open heart surgery. A larger study with clinical outcomes as primary end points is now warranted.
| Introduction |
|---|
|
|
|---|
| This article has been selected for the open discussion forum on the CTSNet Web Site:
http://www.ctsnet.org.discuss
|
In adults, normothermic (3537°C) cardiopulmonary bypass (CPB) has been shown to lead to improved clinical outcome and less organ dysfunction when compared with hypothermic CPB [13]. However, in pediatric open-heart surgery the use of hypothermia is still widely spread in the majority of cardiac surgical centers [4]. The main rationale for body cooling is to protect organs such as the brain, the kidneys, and the heart from ischemic injury by a reduction in metabolic rate, reflected in decreased oxygen consumption [4]. Furthermore hypothermia has been associated with a reduction in the whole body inflammatory response to CPB [57]. Nevertheless, CPB perfusion temperature strategies and their effects on organ functions are largely the result of work carried out on adult human [13] or animal models [5, 6] and the conclusions drawn from those studies cannot necessarily be applied directly to infants or children. Indeed, other groups [7, 8] have recommended the use of normothermic full-flow bypass for pediatric cardiac surgery despite the lack of prospective randomized evidence.
The aim of this study was therefore to examine, in a randomized controlled trial, the effect of CPB temperature on myocardial reperfusion injury, oxidative stress, and inflammatory response in children undergoing repair of simple congenital cardiac malformations.
| Material and Methods |
|---|
|
|
|---|
Anesthetic and Surgical Technique
Anesthetic technique was standardized as reported previously [9]. Temperature was monitored through nasopharyngeal, rectal, and skin probes. On establishment of CPB, the patient was either cooled to a target nasopharyngeal temperature of 28°C or maintained at 3537°C depending on randomization. St Thomas I crystalloid cardioplegia (4 to 6°C) was delivered in an antegrade fashion through the aortic root, as previously reported [10]. Topical cooling with cold saline solution was used in all patients. The CPB flow was kept between 3.0 and 3.5 L·m2
·min1, and hematrocrit values between 25% and 30%. In the hypothermic group rewarming was started just prior to removal of the aortic cross clamp. Patients were rewarmed with a temperature difference of 8°C at the level of the heat exchanger between the blood and the rewarming fluid. Rewarming only took place in the normothermic group if the temperature was less than 36°C. A dopamine infusion was commenced in all patients at an initial rate of 5 mcg·kg·min prior to weaning from CPB. Patients were weaned from CPB once the nasopharyngeal temperature had reached 36°C. After the operation, all patients were admitted to the pediatric intensive care unit and were managed according to the unit protocols [9] by intensivists and pediatric cardiologists blinded to the randomization.
Outcome Variables
Primary end points were the release of troponin I and 8-isoprostane as measurements of myocardial reperfusion injury and oxidative stress, and the release of markers of the whole body inflammatory response (complement activation C3a; and interleukin (IL) -6, -8, and -10). The sample size calculated was based on our previous experience in similar studies on adult and pediatric patients [2, 3, 9, 10], where we have been able to demonstrate differences using groups of between 20 and 30 patients. Effect sizes corresponding to 0.8 to 1.1 standard deviations have been observed for the total area under curves describing the levels of biochemical markers during the first 24 hours after operation; eg, IL-6, IL-8, and troponin I. Therefore, a total sample size of 29 patients in each group was chosen in order to detect a difference between the groups equivalent to 0.75 standard deviations (ie, about the minimum observed in our previous studies) or greater, with 80% power at a 5% significance level (two-tailed). We also recorded all-cause in-hospital mortality and morbidity as previously reported [9, 10]. A full neurologic examination by a pediatric neurologist, blinded to the treatment allocation, was performed preoperatively and on a daily basis postoperatively.
Sample Collection and Analysis
Blood was drawn preoperatively, on removal of the aortic cross clamp, and 30 minutes, 6 hours, and 24 hours thereafter. This was immediately centrifuged at 4°C, at 4,000 rpm for 15 minutes. The resulting plasma was then immediately frozen in liquid nitrogen, prior to storage at 80°C. This was then analyzed for troponin I (enzyme-linked immunosorbent assays (ELISA, Access, Beckman Coulter, Fullerton, CA), 8-isoprostane (EIA, Cayman Chemicals, Ann Arbor, MI), interleukin 6, 8, and 10 (ELISA, Amersham Biosciences, Amersham, UK), and complement activation C3a (ELISA, BD Biosciences Pharmingen, San Jose, CA).
Statistical Analysis
Operative characteristics were compared using the Wilcoxon rank sum test. Postoperative measurements of myocardial reperfusion injury, oxidative stress, and whole body inflammatory response were compared using regression analysis, with and without adjustment for aortic cross-clamp (ACC) time. All analyses were adjusted for preoperative readings. A variety of models describing the correlation structure between repeated measurements on the same patient were examined and the structure leading to the lowest value for the Schwarzs Bayesian information criterion was chosen in each case. All measurements followed a skewed distribution and were transformed to the logarithmic scale for analysis. Changes in treatment effect over time were assessed using the F-test and if statistically significant at the 10% level the treatment difference is reported separately at time points, otherwise an overall effect of treatment is given. Results are presented as geometric means and as a ratio of means with 95% confidence intervals, adjusted for differences in baseline response and ACC time. A post hoc analysis of 8-isoprostane, comparing the response when adjusting for (a) the preoperative reading and CPB time and (b) the preoperative reading, ACC and CPB times, was also carried out. The regression models were fitted using SAS version 8.2 (SAS Institute, Cary, NC). The rank correlation between myocardial reperfusion injury and oxidative stress (as measured by the area under the curve for troponin I [TnI] and 8-isoprostane) and clinical outcomes (duration of ventilation, inotropic support, and total postoperative hospital stay) was assessed for each treatment group separately and overall.
| Results |
|---|
|
|
|---|
|
|
|
|
|
The release of complement activation C3a was similar in the two groups and there was no evidence to suggest statistically significant time-related differences (p = 0.15); the response was similar across the two groups throughout (p = 0.16). Adjusting for ACC time did not change this conclusion; complement activation C3a remained similar in both groups (p = 0.38).
| Comment |
|---|
|
|
|---|
Oxidative Stress and Myocardial Reperfusion Injury
Reperfusion injury is characterized by the formation of oxygen-free radicals such as superoxide and peroxide, which are responsible for cell membrane degradation through lipid peroxidation. Myocardial reperfusion injury has been studied in great detail, and it is now evident that oxidative stress is a major part of the cellular mechanism of the resulting myocardial damage [1114]. The 8-isoprostane has been shown to be a reliable marker for the volume of myocardium exposed to oxidant stress during cardioplegic arrest and acute myocardial infarction [1114].
The increased 8-isoprostane levels in the hypothermic group were associated with elevated TnI release, suggesting an effect of CPB temperature on the degree of myocardial reperfusion injury. The effect on TnI, however, was reduced after adjusting for ACC time. The 8-isoprostane measured in peripheral blood is not a specific marker of myocardial reperfusion injury. It is most likely, therefore, that the higher levels of this marker in the hypothermic group reflect a combination of myocardial and whole body oxidative stress. We can only hypothesize as to the exact source, but as the isoprostanes are breakdown products of lipid peroxidation, any organ system rich in lipids could be responsible. This, we believe, warrants further investigation. The view that normothermic cardiopulmonary bypass may cause rewarming of the heart by collateral blood flow, and from contiguous structures resulting in less effective hypothermic cardioplegic myocardial protection, was not supported by our study. The differences in oxidative stress between the two groups were not translated into differences in clinical outcomes, as demonstrated by the weak correlations between TnI and 8-isoprostane release and ventilation time, inotropic support, and hospital stay.
Inflammatory Response
This study shows that the inflammatory response triggered by CPB during low risk pediatric heart surgery is similar in the hypothermic and normothermic groups. The proinflammatory cytokines levels (IL-6 and IL-8) increased significantly 6 hours postoperatively and remained significantly elevated after 24 hours, indicating the induction of a systemic inflammatory response not temperature dependent. This was associated with a significant increase in complement activation (C3a) 30 minutes after the end of the ischemic time. A similar pattern of proinflammatory cytokines production was seen in neonates after arterial switch operation [15]. Our findings, however, contrast with previous animal data [5, 6], which have documented a reduction of the inflammatory response to CPB by hypothermia compared with normothermia, mainly as a result of reduced white blood cell activation and disturbances of the microcirculation. In contrast to the release of IL-6 and IL-8, and in agreement with previous studies [1618], IL-10 release showed a significant peak as early as 30 minutes after the end of the ischemic time, and tended to return toward preoperative levels after 24 hours. The immediate IL-10 release was significantly higher in the normothermic group and was associated with a lower IL-8 liberation 6 hours postoperatively compared with the hypothermic group. Interleukin 10 is an antiinflammatory cytokine that deactivates monocytes and macrophages and inhibits the synthesis of proinflammatory cytokines such as tumor necrosis factor (TNF)-
and IL-8 [19]. Therefore, early IL-10 liberation during CPB may down-regulate the production of proinflammatory cytokines, and play a protective role in pediatric patients undergoing open heart surgery. The view that normothermia may be associated with an exaggerated inflammatory response to bypass was therefore not supported in this study.
Limitations of the Study
One of the confounding factors in explaining the results of the study is the difference in ischemic and CPB times between the two groups. While it is expected that the CPB times would be shorter in the normothermic group due to the avoidance of time taken to cool and subsequently rewarm, it is surprising that the ACC times were significantly different. Troponin values are known to correspond to the duration of ischemia, and hence we would expect them to be lower in the group with the shorter ACC time. Hence we adjusted for ACC time and even though the difference in TnI levels was then no longer statistically significant, the values were still lower overall in the normothermic group.
Although we did not investigate cognitive outcomes, all patients received a full preoperative and postoperative neurologic examination. Several studies in an adult population have addressed this question with conflicting results [20, 21]. To the best of our knowledge, no data are available in a pediatric population.
The study excluded neonates and patients with complex congenital heart pathologies and was designed to detect changes in biochemical markers but not in clinical outcome. Using estimates for ventilation time, intensive therapy unit (ITU), and hospital stay from a previous study carried out at our institution [10], we calculate that a total sample size of 180 patients would be required to detect a 32% reduction in ventilation time (15 hours), a 23% reduction in length of ITU stay (26 hours), and a 17% reduction in length of hospital stay (1.8 days) with 90% power, assuming a 5% level of statistical significance and a two-tailed test.
Conclusions
In infants and children requiring correction of simple congenital heart defects, normothermic CPB is associated with reduced oxidative stress and similar myocardial reperfusion injury and inflammatory response compared with hypothermic CPB. A larger study with a sample size capable to detect differences in clinical outcome is now warranted.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
generation during coronary reperfusiona potential quantitative marker of oxidant stress in vivo. Circulation 1997;95:2492-2499.
-I and 8-epi-prostaglandin F2
in acute coronary angioplastyevidence for oxidant stress during coronary reperfusion in humans. Circulation 1997;96:3314-3320.
serum levels in response to cardiac surgery J Thorac Cardiovasc Surg 2002;123:451-458.This article has been cited by other articles:
![]() |
M. Caputo, A. Mokhtari, C. A. Rogers, N. Panayiotou, Q. Chen, M. T. Ghorbel, G. D. Angelini, and A. J. Parry The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing open cardiac surgery: A randomized controlled trial J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 206 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. D. Durandy, M. Younes, and B. Mahut Pediatric Warm Open Heart Surgery and Prolonged Cross-Clamp Time Ann. Thorac. Surg., December 1, 2008; 86(6): 1941 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Levionnois and P. Kronen Development of post-pump syndrome in a sheep after mitral valve stenting Lab Anim, October 1, 2008; 42(4): 505 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Rastan, T. Walther, N. A. Alam, I. Daehnert, M. A. Borger, F. W. Mohr, J. Janousek, and M. Kostelka Moderate versus deep hypothermia for the arterial switch operation -- experience with 100 consecutive patients Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 619 - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Eggum, T. Ueland, T. E. Mollnes, V. Videm, P. Aukrust, A. E. Fiane, and H. L. Lindberg Effect of Perfusion Temperature on the Inflammatory Response During Pediatric Cardiac Surgery Ann. Thorac. Surg., February 1, 2008; 85(2): 611 - 617. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |